Harlan W. Waksal
2016 - Kadmon Holdings
In 2016, Harlan W. Waksal earned a total compensation of $13.4M as President and Chief Executive Officer at Kadmon Holdings, a 17% decrease compared to previous year.
Compensation breakdown
| Bonus | $500,000 |
|---|---|
| Option Awards | $12,399,395 |
| Salary | $500,000 |
| Other | $22,723 |
| Total | $13,422,118 |
Waksal received $12.4M in option awards, accounting for 92% of the total pay in 2016.
Waksal also received $500K in bonus, $500K in salary and $22.7K in other compensation.
Rankings
In 2016, Harlan W. Waksal's compensation ranked 290th out of 14,075 executives tracked by ExecPay. In other words, Waksal earned more than 97.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 290 out of 14,075 | 98th |
Division Manufacturing | 92 out of 5,489 | 98th |
Major group Chemicals And Allied Products | 25 out of 1,895 | 99th |
Industry group Drugs | 20 out of 1,538 | 99th |
Industry Pharmaceutical Preparations | 17 out of 1,176 | 99th |
Source: SEC filing on May 10, 2017.
Waksal's colleagues
We found two more compensation records of executives who worked with Harlan W. Waksal at Kadmon Holdings in 2016.
News
Lyra Therapeutics Chairman Harlan Waksal receives $5M in 2022
April 25, 2023
Kadmon Holdings CFO Steven Meehan's 2020 pay jumps 76% to $2.3M
April 1, 2021
Kadmon Holdings CEO Harlan Waksal's 2019 pay jumps 27% to $4.7M
April 2, 2020
Kadmon Holdings CEO Harlan Waksal's 2018 pay jumps 43% to $3.7M
April 2, 2019